Immune Modulatory DC Vaccine Against Brain Tumor | MicrobiomeTrials← Back to trialsNCT03914768
Immune Modulatory DC Vaccine Against Brain Tumor
ENROLLING_BY_INVITATIONPHASE1INTERVENTIONAL
Trial Details
Start: 2026-05-31Est. Completion: 2029-05-31
Enrollment target: 10 participants Locations- Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
- Shenzhen Children's Hospital, Shenzhen, Guangdong, China
- Department of Neurosurgery, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China
Other microbiome trials you might be interested in
High Grade GliomaAstrocytomaAstrocytoma, Grade IIIAstrocytoma, Grade IVDiffuse Intrinsic Pontine GliomaWHO Grade III GliomaWHO Grade IV GliomaMetastatic Brain TumorDiffuse Midline Glioma, H3 K27M-MutantThalamus TumorSpinal TumorIDH1 MutationIDH1 R132IDH1 R132CIDH1 R132HIDH1 R132SIDH1 R132GIDH1 R132LOligodendroglioma
The goal of this study is to determine the efficacy of the study drug olutasidenib to treat newly diagnosed pediatric an…
Aurora, United StatesEst. completion Jun 2029
High Grade GliomaDiffuse Intrinsic Pontine GliomaAnaplastic AstrocytomaGlioblastomaGlioblastoma MultiformeDiffuse Midline Glioma, H3 K27M-MutantMetastatic Brain TumorWHO Grade III GliomaWHO Grade IV Glioma
The goal of this study is to perform genetic sequencing on brain tumors from children, adolescents, and young adult pati…
Aurora, United StatesEst. completion Aug 28, 2029